Avatrombopag

Therapeutic indications

Avatrombopag is indicated for:

Primary chronic immune thrombocytopenia (ITP)

Irrespective of gender only Adults (18 - 65 years old)

Avatrombopag is indicated for the treatment of primary chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 20 mg once daily

Severe thrombocytopenia with chronic liver disease

Irrespective of gender only Adults (18 - 65 years old)

Avatrombopag is indicated for the treatment of severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Oral - 40-60 mg in 2-3 divided doses daily